TBCD p.Ala415Val
c.1244C>T · rs763143236 · VCV429334
Computational evidence
| Protein change | ||
| AlphaMissense | 0.2335 | likely benign |
|---|---|---|
| REVEL | 0.334 | indeterminate |
| SaProt | LLR -10.02 | damaging |
| ⇒ SaProt calls this damaging; AlphaMissense does not; REVEL is indeterminate. | ||
| Splicing | ||
| SpliceAI | <0.2 | all four deltas below 0.2 · C>G here scores Δ0.42 · evaluated, not missing |
| Constraint at this position | ||
| Conservation | phyloP 7.5 | GERP 1.5, phastCons 1 |
| Regional constraint | o/e 0.90 | unconstrained · MANE · 190 kb · p 9.5e-05 · regional, not allelic |
| Overall | ||
| CADD | 25.0 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Finnishnot grpmax-eligible | 0.0188% | 5,330 |
| South Asiangrpmax | 0.00659% | 15,178 |
| East Asian | 0.00446% | 22,440 |
| Remaining individualsnot grpmax-eligible | 0.0032% | 31,224 |
| European (non-Finnish) | 0.00102% | 98,322 |
Finnish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- TBCD
- Protein
- p.Ala415Val
- Coding
- c.1244C>T
- MANE Select
- NM_005993
- dbSNP
- rs763143236
- Type
- single nucleotide variant
- Location
- chr17:82814860 (GRCh38)
- Gene constraint
- LOEUF 0.763 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 90.45 · 6 PDB
Similar variants
- ZNF750 p.Pro415= Likely benign ★ same residue
- TBCD p.Gln330Ter Pathogenic ★★ same condition
- TBCD p.Ala1159Val Uncertain significance ★★ ⚠ same condition
- TBCD p.Ala1162Val Uncertain significance ★★ ⚠ same condition
- TBCD p.Ala394Ser Uncertain significance ★★ ⚠ same condition
- TBCD p.Ala599Thr Uncertain significance ★★ ⚠ same condition
- TBCD p.Ala907Val Uncertain significance ★★ ⚠ same condition
- TBCD p.Arg1107Thr Uncertain significance ★★ ⚠ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/tbcd-p-ala415val (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown